GD
CytoMed Therapeutics Limited
GDTC · NASDAQ
$0.86 +6.87% (+$0.06)
1M -5.70%
Market Cap $13.0M
P/E Ratio -
Div. Yield -
ROE 70.74%
Piotroski F-Score Weak
2/9Valuation
44 /100
Fair P/B 1.99x
P/S 20.28x
PEG N/A
Growth
22 /100
Declining Book val. growth 123.05%
Rev. growth 4.42%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 986.02%
Op. margin 672.19%
Gross margin 20.48%
Quality
1 /100
Poor Asset turnover 0.08x
ROA 60.74%
ROIC 58.88%
Debt
69 /100
Low Current ratio 5.17x
Int. coverage -276.39x
Debt/Equity 0.07x
Stability
13 /100
Unstable Profitable years 0
EPS volatility 46.34%
Beta 0.05x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GDTC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chee Kong Choo
Employees
42
Headquarters
Singapore
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report